Fiche centre
Royal Hallamshire Hospital
Sheffield — United Kingdom
Essais liés8clinical trials
VilleSheffieldlocalisation
PaysUnited Kingdomlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07139743
Essais cliniques associés
8| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| LY3954068 | Alzheimer | Phase 1 | NCT06297590 | A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease | RECRUITING |
| Obecabtagene autoleucel (obe-cel) | SEP | Phase 1 | NCT07139743 | BOBCAT — Obe-cel in Refractory Progressive Forms of Multiple Sclerosis | RECRUITING |
| Phenytoin | SEP | Phase 2 | NCT01451593 | Neuroprotection With Phenytoin in Optic Neuritis | COMPLETED |
| VTx-002 | Sclérose latérale amyotrophique | Phase 1/2 | NCT07287397 | Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS | RECRUITING |
| VX-670 | Myopathies | Phase 1/2 | NCT06185764 | Galileo — A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) | ACTIVE_NOT_RECRUITING |
| AOC-1020 | Myopathies | Phase 3 | NCT07038200 | FORTITUDE-3 — A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD | RECRUITING |
| Ocrelizumab | SEP | Phase 3 | NCT04035005 | O'HAND — A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| IMU-838 tablets | SEP | Phase 3 | NCT05201638 | ENSURE-2 — Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis | ACTIVE_NOT_RECRUITING |